BrightSpire Capital heads into its Q2 2026 earnings release with short sellers notably less convicted than they were a month ago.
The most striking positioning shift is the rapid unwind of short interest. Bearish exposure has fallen by roughly 22% over the past month and nearly 20% in a single week, pulling the short interest level down to 2.8% of the free float — a low reading by any measure. The pullback is dramatic: shorts peaked near 7 million shares in late June before retreating to around 3.6 million now. Lending conditions confirm the squeeze on the thesis is one-sided — borrow availability is exceptionally loose at over 1,400% relative to shares currently on loan, meaning capital is not scarce for anyone who wants to press a short position. Cost to borrow is low at 0.57%, though it has crept up about 11% on the week, a minor uptick that doesn't yet signal any renewed conviction from bears. Options positioning reinforces the tilt toward bulls: the put/call ratio has dropped sharply to 0.57, well below its 20-day average of 11, reflecting a near-total collapse in demand for downside protection relative to where it spent most of June and early July.
The bull and bear cases reflect a contested recovery story in commercial real estate credit. Bulls point to a $3.5 billion portfolio target, improving loan origination activity, and a stock trading below book value at around 0.70x price-to-book — a valuation that embeds a material discount relative to NAV. The forward yield factor ranks in the 87th percentile on ORTEX's dividend score, and the forward EPS growth trajectory is exceptional on paper. BTIG upgraded the stock to Buy in April, setting a $7.00 target against a current price of $5.24. Bears counter that the REIT operates in a crowded, rate-sensitive market where leverage and external financing risk can rapidly erode returns — a concern Barclays has anchored with a persistent Underweight rating and a $6.00 target. Notably, the stock has underperformed even a modest recovery: while peer gained nearly 3% on the week, BRSP slipped 3.1%. Closest correlation peers and also declined, but less sharply.
One note of caution on the institutional side: the ORTEX short score has eased to 36 from roughly 39-40 a week ago, confirming the de-risking trend in positioning. However, the ORTEX factor score on EPS momentum is weak — ranked in just the 11th percentile over 90 days and the 37th percentile over 30 days. EPS surprise ranks in only the 18th percentile. The most recent earnings history carries limited precedent: the May 2026 print produced a near-flat one-day move of 0.5%, while the April print delivered a 4.4% one-day drop.
The Q2 report will therefore test whether improving origination activity and credit resolution have translated into distributable earnings growth that can justify both the dividend and the stock's recovery from its June lows.
See the live data behind this article on ORTEX.
Open BRSP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
